GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Asiatic Laboratories Ltd (DHA:ASIATICLAB) » Definitions » Equity-to-Asset

Asiatic Laboratories (DHA:ASIATICLAB) Equity-to-Asset : 0.00 (As of . 20)


View and export this data going back to 2024. Start your Free Trial

What is Asiatic Laboratories Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Asiatic Laboratories's Total Stockholders Equity for the quarter that ended in . 20 was BDT0.00 Mil. Asiatic Laboratories's Total Assets for the quarter that ended in . 20 was BDT0.00 Mil.

The historical rank and industry rank for Asiatic Laboratories's Equity-to-Asset or its related term are showing as below:

DHA:ASIATICLAB's Equity-to-Asset is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.58
* Ranked among companies with meaningful Equity-to-Asset only.

Asiatic Laboratories Equity-to-Asset Historical Data

The historical data trend for Asiatic Laboratories's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asiatic Laboratories Equity-to-Asset Chart

Asiatic Laboratories Annual Data
Trend
Equity-to-Asset

Asiatic Laboratories Semi-Annual Data
Equity-to-Asset

Competitive Comparison of Asiatic Laboratories's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Asiatic Laboratories's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Asiatic Laboratories's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Asiatic Laboratories's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Asiatic Laboratories's Equity-to-Asset falls into.



Asiatic Laboratories Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Asiatic Laboratories's Equity to Asset Ratio for the fiscal year that ended in . 20 is calculated as

Equity to Asset (A: . 20 )=Total Stockholders Equity/Total Assets
=/
=

Asiatic Laboratories's Equity to Asset Ratio for the quarter that ended in . 20 is calculated as

Equity to Asset (Q: . 20 )=Total Stockholders Equity/Total Assets
=/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Asiatic Laboratories  (DHA:ASIATICLAB) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Asiatic Laboratories Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Asiatic Laboratories's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Asiatic Laboratories (DHA:ASIATICLAB) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Siddeshwari Circular Road, 42-43, Treasure Island (5 th Floor) Shantinagar, Dhaka, BGD, 1217
Asiatic Laboratories Ltd is engaged in manufacturing and marketing of a wide range of the rapeutical medicines pharmaceutical products in the categories of Biological, Non-Biological & Sterile Pharmaceutical dosage. It has 80 generic molecules comprising therapeutic classes like antibiotics, antihistamines, bronchodilators, vitamins-minerals, antiulcerants, laxatives, gastroprokinetics, antihematinic, anthelmentics, CNS drugs, respiratory drugs, NSAIDs, dermatological preparations and sterile ophthalmic preparations.

Asiatic Laboratories (DHA:ASIATICLAB) Headlines

No Headlines